Galapagos NV
GLPG
#4533
Rank
C$3.04 B
Marketcap
C$46.21
Share price
-0.73%
Change (1 day)
37.60%
Change (1 year)

Earnings for Galapagos NV (GLPG)

Earnings in 2025 (TTM): -C$0.75 Billion

According to Galapagos NV's latest financial reports the company's current earnings are C$0.32 Billion. In 2024 the company made an earning of -C$7.89 Million, an increase over its 2023 earnings that were of -C$45.76 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Galapagos NV from 2015 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$0.75 Billion9344.61%
2024 -C$7.89 Million-82.77%
2023 -C$45.76 Million-85.59%
2022 -C$0.32 Billion60.71%
2021 -C$0.2 Billion-60.08%
2020 -C$0.5 Billion-331.44%
2019 C$0.21 B-523.76%
2018 -C$50.48 Million-72.34%
2017 -C$0.19 Billion-329.59%
2016 C$79.48 M-144.3%
2015 -C$0.18 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$44.18 B-6,184.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
C$11.10 B-1,628.56%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
C$2.26 B-411.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$12.41 B-1,809.31%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
C$31.49 B-4,437.01%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$17.85 B-2,558.70%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
C$12.71 B-1,851.12%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
-C$72.94 Million-89.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$2.41 B-432.84%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel